Abstracts Archive - Page 116 of 1683 - ATC Abstracts

2022 American Transplant Congress
Baseline Findings from the UREAACT Trial to Improve Medication Adherence in Youth with Kidney Transplants
S. Amaral¹, P. Kwong², J. Zhu², R. George³, N. Rodig⁴, B. Warady⁵, J. Smith⁶, A. Bobrowski⁷, D. Matossian⁸, N. Zelikovsky⁹, L. Schwartz¹, P. Reese², R. Goldfarb Terry¹, J. Reason², A. Chung¹, S. Furth¹
¹CHOP, Phila, PA, ²UPenn, Phila, PA, ³CHOA, Atlanta, GA, ⁴Boston Children's, Boston, MA, ⁵Children's Mercy, Kansas City, MO, ⁶Seattle Children's, Seattle, WA, ⁷Cleveland Clinic, Cleveland, OH, ⁸Lurie Children's, Chicago, IL, ⁹LaSalle Univ, Phila, PA
*Purpose: This abstract describes the design and baseline characteristics of participants in the U-REAACT trial, a study to improve medication adherence in youth with kidney…
2022 American Transplant Congress
Biopsy Characteristics of Kidneys from a Single Large OPO
S. Bunnapradist¹, T. Seto², A. Cohen², T. Rosenthal¹, G. Danovitch¹
¹David Geffen School of Medicine, Los Angeles, CA, ²One Legacy, Los Angeles, CA
*Purpose: As deceased donor pool have expanded, kidney biopsy has been increasingly used to help determine organ suitability for transplant. There are concerns that biopsy…
2022 American Transplant Congress
Case Times For Brain Dead Donors: Longer Is Not Better, No Impact Of Longer Case Time On Organ Yield Or OPO Performance Tier
M. J. Moritz¹, R. Hasz¹, H. Nathan¹, E. Hunt², S. Noreen³, A. Toll⁴
¹Gift of Life Donor Program, Philadelphia, PA, ²Surgery, Lehigh Valley Health Network, Allentown, PA, ³United Network for Organ Sharing, Richmond, VA, ⁴Research, United Network for Organ Sharing, Silverdale, WA
*Purpose: Having observed the steady increase in case times, we wished to examine if this has impacted organ yield*Methods: We conducted a retrospective cohort study…
2022 American Transplant Congress
Waitlist Meldna Variation One-year Prior To Liver Transplant Predicts Length Of Stay At The Time Of Transplant
L. Pruinelli¹, S. Olson¹, J. Zhou¹, M. Nguyen¹, J. Schold², T. Pruett¹, S. Ma¹, G. Simon¹
¹University of Minnesota, Minneapolis, MN, ²Cleveland Clinic Foundation, Cleveland, OH
*Purpose: MELDNa is used to estimate 90-day mortality in the waitlist. MELDNa variation between cross-sections has shown a better predictivity than when analyzed as a…
2022 American Transplant Congress
Outcomes of Kidney Transplants in Children: A Single-Center Experience
S. Shaikhouni¹, C. Hanna², I. Sekhon¹, H. Amer¹, M. Prieto³, C. H. Cramer²
¹Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ²Pediatric Nephrology and Hypertension, Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ³Division of Transplantation Surgery, Department of Medicine, Mayo Clinic, Rochester, MN
*Purpose: Over the past decades, immunosuppression regimen protocols, surgical techniques, and outcomes in pediatric kidney transplants (PKT) have evolved. This study describes our center’s experience…
2022 American Transplant Congress
Outcome of Pre-Emptive Kidney Transplantation in Children Under 6 Years of Age; A Single Center Experience in Japan
Y. Aoki¹, Y. Hamasaki¹, J. Hashimoto¹, A. Zaitsu², M. Kubota¹, M. Muramatsu¹, T. Kawamura¹, S. Shishido², K. Sakai¹
¹Nephrology, Toho University Faculty of Medicine, Tokyo, Japan, ²Pediatric Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
*Purpose: Kidney transplantation (KT) is the preferred treatment for pediatric end stage renal disease, and pre-emptive kidney transplantation (PEKT) may reduce morbidity and mortality. KT…
2022 American Transplant Congress
Deceased Donor Procurement Biopsy Practices, Interpretation, and Histology-Based Decision Making: A Survey of US Transplant Centers
V. Fleetwood¹, D. Axelrod², Y. Caliskan¹, H. Randall¹, J. Wellen³, M. Lichtenberger³, C. Dedert¹, R. Rothweiler⁴, G. F. Marklin⁴, D. Brockmeier⁴, M. A. Schnitzler¹, S. A. Husain⁵, S. Mohan⁵, B. Kasiske⁶, M. Cooper⁷, K. L. Lentine¹
¹Saint Louis U., St. Louis, MO, ²U. of Iowa, Iowa City, IA, ³WUSTL, St. Louis, MO, ⁴Mid-Am. Trans., St. Louis, MO, ⁵Columbia U., New York, NY, ⁶Hennepin Healthcare, Minneapolis, MN, ⁷MedStar Transpl. Inst., Washington, DC
*Purpose: In light of contemporary controversies on the utility of kidney procurement biopsies in predicting allograft outcomes and guiding organ acceptance, we surveyed transplant providers…
2022 American Transplant Congress
Sodium-Glucose Co-Transporter 2 Inhibitors; Short-Term Outcome in Diabetic Kidney Transplant Recipients
J. Yagan¹, T. S. Mahmoud¹, A. Hasan², O. Gheith¹, n. El-Serwy¹, S. Rida¹, M. Mostafa¹, M. Shaker¹, P. Nair¹, T. Alotaibi¹
¹Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait, ²Immunometabolism, Dasman Diabetes Center, Kuwait, Kuwait
*Purpose: The idea of using SGLT2i in kidney transplant recipients (KTR) is a legitimate one after the recent encouraging data for their use in other…
2022 American Transplant Congress
Early Outcomes Since Implementation of New Kidney Allocation System
K. Shah, F. Siddiqui, P. N. Chotai, A. Logan, A. Schenk, K. Washburn, A. Limkemann
Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: The new Kidney allocation system (nKAS) implemented for optimization of organ placement. Like other organ allocation systems, kidney has been redefined from donation service…
2022 American Transplant Congress
DEPTOR: A Novel Endothelial-Specific Regulator of Cell-Intrinsic Anti-Inflammation Following Transplantation
C. Testini¹, S. Bose¹, K. Liu¹, S. Kong¹, E. Flynn¹, M. Miovski¹, J. Leyva-Rangel¹, M. Laplante², J. Wedel¹, D. M. Briscoe¹
¹Boston Children's Hospital and Harvard Medical School, Boston, MA, ²Laval University, Quebec, QC, Canada
*Purpose: Recent studies have highlighted a paradigm whereby the maintenance of normal tissue homeostasis and the prevention of chronic inflammation is dependent on the active…